Eris Lifesciences Limited (ERIS) — Cash Flow Quality Index
Eris Lifesciences Limited (ERIS) has a Cash Flow Quality Index of 1.00x as of September 2025. Operating cash flow of Rs2.39 Billion exceeds net income of Rs2.38 Billion, indicating high earnings quality where cash backs reported profits. Explore how well can Eris Lifesciences Limited service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Eris Lifesciences Limited Cash Flow Quality Index (2012–2026)
Historical Cash Flow Quality Index for Eris Lifesciences Limited across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ERIS cash flow conversion.
Annual Cash Flow Quality Index for Eris Lifesciences Limited (2012–2026)
Year-by-year earnings quality comparison for Eris Lifesciences Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 0.54x | Rs3.47 Billion | Rs6.39 Billion | ▼ -82.1% |
| 2025 | 3.03x | Rs10.65 Billion | Rs3.52 Billion | ▲ +144.1% |
| 2024 | 1.24x | Rs4.86 Billion | Rs3.92 Billion | ▲ +72.0% |
| 2023 | 0.72x | Rs2.92 Billion | Rs4.05 Billion | ▼ -15.7% |
| 2022 | 0.86x | Rs3.78 Billion | Rs4.42 Billion | ▼ -10.1% |
| 2021 | 0.95x | Rs3.75 Billion | Rs3.94 Billion | ▲ +16.3% |
| 2020 | 0.82x | Rs2.71 Billion | Rs3.31 Billion | ▲ +16.4% |
| 2019 | 0.70x | Rs2.23 Billion | Rs3.17 Billion | ▼ -6.5% |
| 2018 | 0.75x | Rs2.35 Billion | Rs3.12 Billion | ▼ -0.8% |
| 2017 | 0.76x | Rs2.00 Billion | Rs2.64 Billion | ▼ -11.0% |
| 2016 | 0.85x | Rs1.31 Billion | Rs1.54 Billion | ▲ +3.4% |
| 2015 | 0.82x | Rs900.57 Million | Rs1.09 Billion | ▼ -9.7% |
| 2014 | 0.91x | Rs896.24 Million | Rs983.25 Million | ▲ +99.3% |
| 2013 | 0.46x | Rs380.15 Million | Rs831.39 Million | ▼ -44.2% |
| 2012 | 0.82x | Rs302.99 Million | Rs369.43 Million | — |